Co-Founder and Head, Business Development and Licensing @ (October 2020 - December 2021)
Co-founder, Chief Business Officer @ (February 2019 - October 2020)
CEO and President, USA @ (January 2016 - October 2019)
Co-founder, Director, UK @ (May 2009 - August 2019)
Managing Partner @ (April 2012 - January 2016)
Founder and President @ (May 2013 - September 2019)
Business Development Advisor (USA) @ (September 2012 - May 2019)
Strategy and BD Advisor @ (January 2016 - August 2018)
Strategy and BD Advisor @ (April 2016 - May 2017)
Business Development Advisor (USA) @ (June 2015 - March 2017)
Strategy and BD advisor @ (January 2011 - October 2011)
Head of Business Development @ (August 2005 - May 2009)
Business Development Manager @ (November 2001 - March 2005)
Business Development Analyst @ (November 2000 - November 2001)
Business Development Assistant @ (August 1999 - November 2000)
Robert Johnson Education
London Business School
(Corporate Finance, Finance)
2002-2003
Nottingham University Business School
Bachelor of Science (Biology)
1996-1999
Oundle School 1995-1999
Robert Johnson Skills
Biopharmaceuticals
Biotechnology
Business Development
Cancer
Clinical
Commercialization
Drug Development
Due Diligence
Fundraising
Leadership
Licensing
Life Sciences
Lifesciences
Oncology
Partnering
Pharmaceutical Industry
Pharmaceuticals
Strategy
Vaccines
Robert Johnson Summary
Robert Johnson, based in London, GB, is currently a Chief Executive Officer at Kesmalea Therapeutics. Robert Johnson brings experience from previous roles at Foothold America, Insmed Incorporated, Adrestia Therapeutics and Affinia Therapeutics. Robert Johnson holds a 2002 - 2003 London Business School. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Business Development, Cancer, Clinical and more. Robert Johnson has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Robert Johnson?
Find contact details for 700 million professionals.